NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NRTI)
Videx is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretroviral medications. Videx is also referred to by the drug names Didanosine and Dideoxyinosine, and by the abbreviation DDI.
Videx is an antiviral medication of the nucleoside reverse transcriptase inhibitor (NRTI) class. Videx is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Videx is taken once or twice a day.
Videx comes in delayed-release capsule and oral solution forms.
The FDA-approved label for Videx lists common side effects including mild rash, headache, and diarrhea.
Rare but serious side effects listed for Videx include severe hypersensitivity reactions, lactic acidosis (a metabolic disorder), and hepatomegaly (enlarged liver) with steatosis (fatty degeneration).
For more details about this treatment, visit:
Videx EC – RxList
Overview of HIV Treatments – AIDS.gov